Australia markets closed

NewAmsterdam Pharma Company N.V. (NAMSW)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
9.39-0.12 (-1.26%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.08
52-week change 3682.50%
S&P500 52-week change 326.49%
52-week high 314.67
52-week low 30.99
50-day moving average 310.12
200-day moving average 35.53

Share statistics

Avg vol (3-month) 310.44k
Avg vol (10-day) 32.33k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 830.16M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends N/A
Most-recent quarter (mrq)N/A

Profitability

Profit margin 0.00%
Operating margin (ttm)-3,960.17%

Management effectiveness

Return on assets (ttm)-24.82%
Return on equity (ttm)-54.33%

Income statement

Revenue (ttm)6.86M
Revenue per share (ttm)0.08
Quarterly revenue growth (yoy)-83.80%
Gross profit (ttm)N/A
EBITDA -198.54M
Net income avi to common (ttm)-228.69M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)481.15M
Total cash per share (mrq)5.35
Total debt (mrq)43k
Total debt/equity (mrq)0.01%
Current ratio (mrq)8.17
Book value per share (mrq)10.84

Cash flow statement

Operating cash flow (ttm)-163.96M
Levered free cash flow (ttm)-82.2M